4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shanghai Haohai Biological Technology Co., Ltd. (6826) operates in the Biotechnology industry and is headquartered in Shanghai, China with about 2,110 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 6826 reported CNY 2.4B in revenue and CNY 251M in net income.
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 2.4B | CNY 2.7B | CNY 2.6B | CNY 2.1B |
| Gross Profit | CNY 1.7B | CNY 1.9B | CNY 1.9B | CNY 1.4B |
| Operating Income (EBIT) | CNY 317M | CNY 446M | CNY 438M | CNY 220M |
| Net Income | CNY 251M | CNY 420M | CNY 416M | CNY 180M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 229M) | (CNY 260M) | (CNY 68M) | (CNY 122M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 6.7B | CNY 7.1B | CNY 7.1B | CNY 6.9B | — |
| Total Liabilities | CNY 1.1B | CNY 1.2B | CNY 1.1B | CNY 990M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6826 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms